
Radio and PodcastLive Radio & PodcastsFetching episode details...
Radio and PodcastLive Radio & PodcastsFetching episode details...
Radio and PodcastLive Radio & Podcasts
No Label: Michael Irizarry, MD, MPH Dr. Michael Irizarry, Senior Vice-President, Clinical Research, Eisai, Nutley, NJ, discusses the evidence supporting subcutaneous lecanemab for early Alzheimer disease, including dosin...
Subcutaneous Lecanemab for Early Alzheimer Disease: Evidence, Safety, and Patient Selection is an episode from NeuroFrontiers by ReachMD. No Label: Michael Irizarry, MD, MPH Dr. Michael Irizarry, Senior Vice-President, Clinical Research, Ei...
This episode belongs to NeuroFrontiers.
Use the player on this page to stream the episode online.
Published Aug 20, 2026, 00:11:37 long, audio available.